Search

everythinglearnresearchcommunity

for

Search:↓

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Urologists should screen for mental health issues before and during finasteride treatment.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Finasteride does not negatively affect male reproductive function.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Most care for benign prostatic hyperplasia follows guidelines, but 5-α reductase inhibitors are often used incorrectly.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Men with lower education levels are more likely to have erectile dysfunction if they have coronary artery disease.

Finasteride use is not clearly linked to an increased risk of male breast cancer.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Post-finasteride syndrome is rarely linked to sexual and systemic side effects.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Dutasteride safely treats hair loss without harming sexual function.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.